INTRADIGM CORPORATION
Patent Owner
Stats
- 0 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- May 10, 2012 most recent publication
Details
- 0 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 277 Total Citation Count
- Nov 04, 2002 Earliest Filing
- 32 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
- No Technology to Display
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
- No Recent Patents to Display
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2012/0115,923 Sirna Compositions Promoting Scar-Free Wound Healing of Skin and Methods for Wound TreatmentAbandonedDec 29, 06May 10, 12[A61K, C12N, A61P]
2011/0190,375 COMPOSITIONS COMPRISING CMYC SIRNA AND METHODS OF USE THEREOFAbandonedJun 11, 09Aug 04, 11[A61K, C07H, C12N, A61P]
2011/0124,710 COMPOSITION AND METHODS OF RNAI THERAPEUTICS FOR TREATMENT OF CANCER AND OTHER NEOVASCULARIZATION DISEASESAbandonedJan 13, 11May 26, 11[C07H, A61K, C12N, A61P]
2011/0105,588 COMPOSITIONS COMPRISING NOTCH1 SIRNA AND METHODS OF USE THEREOFAbandonedMar 12, 09May 05, 11[A61K, C07H, C12N, A61P]
2011/0065,644 COMPOSITIONS COMPRISING HUMAN PCSK9 AND APOLIPOPROTEIN B SIRNA AND METHODS OF USEAbandonedMar 09, 09Mar 17, 11[A61K, C07H, C12N, A61P]
2011/0053,861 COMPOSITIONS COMPRISING NUCLEAR FACTOR-KAPPA B (NF-KB) SIRNA AND METHODS OF USEAbandonedMar 12, 09Mar 03, 11[A61K, C07H, C12N, A61P]
2011/0053,862 COMPOSITIONS COMPRISING SURVIVIN SIRNA AND METHODS OF USE THEREOFAbandonedMar 09, 09Mar 03, 11[A61K, C07H, C12N, A61P]
2011/0046,067 COMPOSITIONS COMPRISING HUMAN EGFR-siRNA AND METHODS OF USEAbandonedJun 20, 08Feb 24, 11[A61K, C07H, C12N, A61P]
7893243 Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseasesExpiredJun 29, 07Feb 22, 11[C07H, A61K]
7893244 Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseasesExpiredFeb 08, 08Feb 22, 11[C07H, A61K]
2011/0038,849 INHIBITORY POLYNUCLEOTIDE COMPOSITIONS AND METHODS FOR TREATING CANCERAbandonedDec 21, 06Feb 17, 11[A61K, C07H, C12N, A61P, C07K]
2011/0015,249 METHODS AND COMPOSITIONS FOR TREATMENT OF CANCER AND OTHER ANGIOGENESIS-RELATED DISEASESAbandonedJul 03, 08Jan 20, 11[A61K, C07H, C12N, A61P]
2010/0298,409 COMPOSITIONS COMPRISING STAT3 SIRNA AND METHODS OF USE THEREOFAbandonedSep 17, 08Nov 25, 10[C07H, A61K, C12N, A61P]
2010/0286,241 COMPOSITIONS COMPRISING K-RAS SIRNA AND METHODS OF USEAbandonedSep 18, 08Nov 11, 10[A61K, C07H, C12N, A61P]
2010/0279,919 COMPOSITIONS COMPRISING HUMAN INTEGRIN-LINKED KINASE-SIRNA AND METHODS OF USE THEREOFAbandonedSep 04, 08Nov 04, 10[A61K, C07H, C12N, A61P]
2010/0280,097 COMPOSITIONS COMPRISING HIF-1 ALPHA SIRNA AND METHODS OF USE THEREOFAbandonedSep 18, 08Nov 04, 10[A61K, C07H, C12N, A61P]
2010/0273,858 COMPOSITIONS COMPRISING STAT5 SIRNA AND METHODS OF USE THEREOFAbandonedSep 17, 08Oct 28, 10[A61K, C07H, C12N, A61P]
7786092 Composition and method of RNAi therapeutics for treatment of cancer and other neovascularization diseasesExpiredApr 09, 09Aug 31, 10[A61K, C07H]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.